Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

"Declarations Ethics approval and consent to participateThis study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee at the Medical Faculty of the Rheinische Friedrich-Wilhelms-University Bonn (number: 344/20). Patients gave written informed consent for the collection of biomaterials. FundingThe authors declare that they have received no specific funds, grants, or other support for conducting this study. This work was supported by the Open Access Publication Fund of the University of Bonn. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding Open Access funding enabled and organized by Projekt DEAL. Funding The authors declare that they have received no specific funds, grants, or other support for conducting this study. This work was supported by the Open Access Publication Fund of the University of Bonn."